Did HHS Azar Just Usurp Trump On Corporate Parental Rights In International Gerrymandering Policy?

Why was Azar in Taiwan talking about a foreign national policy of another nation?

Was Azar granted any authority to speak on behalf of the United States?

I would love to see those memoranda because I find this behavior to be deeply disturbing.

DHHS's only authority when dealing with a foreign nation should be about CDC sub-recipient grant management, which should be about NIH and their tiny human lab rat activities.

Any such concerns could have been referred to the DHHS OIG to be referred out to DOJ to be referred out to the proper jurisdictions(s) to address any such issues with private research funded through public dollars.

What that has to do with shaping another nation's foreign policy, I have no idea, but we should ask Emperor Pence, because he has a long standing relationship with Eli Lilly and the Vice President is over foreign policy, where, the President is over domestic policies.

The Secretary of State has the signatory authority to sign off on any foreign policy engagements, but, hey, what do I know?

I know this looks like a usurpation of executive power.

I am quite sure there are those who are assigned to do real time field observations on this activity. 

But, just in case no will take the time out of their day to find out why Azar would be so brazenly bold to falsely advise Trump, while, from what I can see in a cursory glance, personally inure himself, in his official capacity of public office, to advocate for a foreign corporation, of which, he more than likely is still generating revenue, as a primary stakeholder of Eli Lilly, but, hey, what do I know?

I know Eli Lilly is in Taiwan and I bet Emperor Pence can tell us about his days when he was sending lots of emails back and forth to his friends, when he was in Indiana, that he does not want to let us read the contents, thereof.

Probably trafficking tiny humans stuff.

Eli Lilly Growth Study Program

The Genetics and NeuroEndocrinology of Short Stature International Study (GeNeSIS) Consent For Data Collection: Core Program

Protocol Description

https://www.humatrope.com/

The main objective of this multicenter international study is the collection and analysis of data regarding safety and effectiveness of Humatrope® for the treatment of growth-hormone deficiency and other growth disorders. This study provides information to doctors prescribing growth hormone to treat children and adolescents, ultimately helping physicians to use these products more effectively.

The GeNeSIS study includes a core study and 5 sub-study modules: DNA Analysis, Growth Prediction, SHOX Deficiency, Neoplasia, and Idiopathic Short Stature. Objectives of the sub-studies are: to characterize gene defects associated with hypopituitarism, growth disorder or short stature; to develop accurate growth prediction models using clinical and biochemical data; to characterize the clinical, endocrine and other features associated with SHOX deficiency and related disorders; to characterize the natural history of neoplastic disease in children evaluated or treated for endocrine or growth disorders; and to examine the variability among genes, proteins and other biomarkers that may be related to growth in children in the United States who receive Humatrope for treatment of idiopathic short stature. (a.k.a. protein deficiencies).

Eligibility Criteria

Children of either sex who are being treated with Humatrope for growth failure are eligible to participate in the core study. Core study participants may also participate in applicable sub studies, through separate consents.

Boys: All ages

Girls: All ages

Growth failure is a fancy term for starving tiny humans whose parents have failed to provide for the best interests of the child (a.k.a. "The Poors" - always said with clinched teeth because there is never an issue when it comes to parental consent to use kids as lab rats when you own them through one of your corporate shape shifting NGOs.)

Requirements

Participation will only involve data collection and annual blood draws, starting during each participant’s first treatment with growth hormone and will continue during subsequent routine visits with the child’s doctor. The study will collect and record all medical record information from lab rat tests, x-rays and clinic visits.

Visits: None beyond normal clinical care

Duration: Until patient is no longer seen in clinic (a.k.a. "death.", but then again, we have all the identification data to continue billing to Medicaid for cost reimbursements).

Status: Open for Enrollment

Source(s) of Support

Eli Lilly and Company

Primary Investigator

Oscar Escobar, MD

Contact Information

To get started, please contact:

Ana Diaz, RN

412-692-6862

or

Virginia Stefanick, RN

412-692-7178

Move channel list right

Eli Lilly Basketball Clinic - Taipei, Taiwan https://t.co/ANWuFoeKOs via @pacers

— Beverly Tran (@beverlytran) August 12, 2020

Eli Lilly Basketball Clinic - Taipei, Taiwan

October 12, 2013 - On Saturday, The Pacers hosted a basketball clinic in conjunction with Eli Lilly. The purpose of the clinic was the promote healthy living among the youth of Taipei, Taiwan.

I also know one of Azar's primary platforms in DHHS is research and innovation, which means you need a vehicle to access your human lab rat populations, where, in this instance, is just so beautifully packaged for our viewing experience on the residuals of the peculiar institution, which is probably why Azar is doing what he is doing.

Always remember, corporations are people, too, with religious beliefs, who can adopt tiny humans, to provide parental consent for lab ratting.

#maytheheavensfall

Lilly Named One of America's Best Adoption-Friendly Workplaces

Voting is beautiful, be beautiful ~ vote.©

Emperor Mike Pence, Jonestown & Trafficking Tiny Humans In The Name Of The Prolife Corporate Parental Rights Tax Exempt God

Jim Jones seems to have spearheaded, with help, of course, the very first model of stealin' the children, land & vote because he is from Indiana and so is Emperor Mike Pence.

I am quite sure there are those who are now mumbling outloud, in a failed attempt to turn away, and go to another link, in knowing that I am intentionally foreshadowing a complete implosion of your sacred cognitive dissonance, because you know you must continue reading.

Jim Jones was not just into the implementation of the first transposable model in the acquisition of human goods, but had launched the first chattel ranching model in human asset forfeiture.

Jim Jones was gerrymandering and it looks like he had Eli Lilly as a fan.

Jonestown FBI Vault

Six Years With God

Jones Appointment to San Francisco Housing Authority
On October 18, 1976, almost a year after he was elected as Mayor of San Francisco, George Moscone appointed Jim Jones to the San Francisco Housing Authority, the agency with jurisdiction over public housing in the city. The appointment has been interpreted as an indication both of Jones’ power in the city and of his weakness in the political realm.

It was a victory for Jones in several respects. The position gave the Temple leader a chance to turn his political rhetoric delivered from the pulpit into action, and Jones spoke up for the poor and minorities whom the Authority was supposed to serve. The new platform also gave him new audiences and more access to press coverage. Eventually, after becoming chair of the commission, he was able to hire three Temple leaders to positions on Housing Authority staff.

There were aspects of the appointment which were disappointing, however. The Temple’s active support of Moscone the previous year may — or may not — have been pivotal in the mayor’s victory, but the interval of 11 months between the election and the appointment acted to undermine Jones’ presentation of himself as kingmaker. Just as telling is that, even though Temple spokesman Mike Prokes served on Moscone’s committee to submit and review names for appointments to commissions in the new administration, neither Jones nor any other Temple names were among the first 100 nominations. And when Jones finally was selected for a position in March 1976, it was to the city’s Human Rights Commission. As Tim Reiterman point out in his book Raven, the appointment might have been “an appropriate place for a liberal preacher. But to Jones, it was a lateral appointment – the same position he had held 15 years earlier in Indianapolis” (p. 268). Jones declined the initial offer, and seven months later, Moscone made the second appointment.

The Temple leader  served on the Housing Authority for less than a year. In August 1977, Jones embarked on his final trip to Guyana, and he did not leave Jonestown for the rest of his life.

Appointment of Jim Jones to San Francisco Housing Authority by Beverly Tran on Scribd

FUN FACT! SAN FRANCISCO HAS A LAND BANK AUTHORITY

Peoples Temple members included attorneys who assisted Rev. Jones and other members on legal questions ranging from obtaining guardianships of children to operating nonprofit corporations that were primarily engaged in acquiring property for the Peoples Temple. P2

Placement of Foster Care Children With Members of the Peoples Temple, General Accounting Office Preliminary... by Beverly Tran on Scribd

In 2013 “cutting a place for a lookout” hasresulted in amajor new strategy

to attract intellectual talent and promote economic development in

Indiana. An Endowment-funded study conducted for BioCrossroads by

the Battelle Technology Partnership Practice examined the research

interests and capacities of Indiana’s top life sciences companies and

research universities. This study revealed many mutual interests and

capacities and resulted in the formation of the Indiana Biosciences

Research Institute, launched through a public-private partnership led by

Indiana Gov. Mike Pence and EliLilly and Company Chairman, President

and CEO John Lechleiter. The Institute raised $50 million in 2013 for the

first phase of its development, including $25 million from the state of

Indiana, $10 million from the Endowment and $15 million from Eli Lilly

and Company, Roche Diagnostics, Dow AgroSciences, Indiana University

Health and Indiana University

http://indianadisciples.org/commissions/commission-on-ministry/lilly-grant/flourish/

In an effort to alleviate some of the economic challenges facing pastoral leaders, the Christian Church in Indiana in partnership with Lilly Endowment Inc. has created the FLOURISH! Program.

Central Indiana Corporate Partnership

https://lillyendowment.org/wp-content/uploads/2017/04/annualreport2013.pdf

http://www.newlifesolutions.org/about/

Voting is beautiful, be beautiful ~ vote.©